About US
Contact us
-
AstraZeneca's Tagrisso, headed for big sales boost, cuts lung cancer recurrence by 83%In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the public is getting a look at what prompted2020/5/28
-
Merck's Keytruda doubles time to disease progression in certain colorectal cancer patientsThe results are out, and they’re practice-changing: Merck’s Keytruda can double the time to disease worsening in patients with certain types of colorectal cancer. The immuno-oncology star kept cancer2020/5/28
-
Pfizer, Merck KGaA's Bavencio lines up for bladder cancer edge with survival winIn a bladder cancer field chock-full of checkpoint inhibitors, Pfizer and Merck KGaA’s Bavencio has a chance to get ahead thanks to new data in post-chemo patients. In a phase 3 study, Bavencio (avel2020/5/27
-
Immunomedics' new CEO hits COVID-19 exit, takes $1M on his way outThe COVID-19 crisis has stalled clinical development activities and drug launches. Now, it has led to the sudden departure of a freshly appointed biopharma CEO. Just over a month afterjoining Immunom2020/5/26
-
Roche hooks up with Gilead for Actemra-remdesivir combo trial in COVID-19The COVID-19 pandemic created an unexpected boost for Roche when health facilities in China started snapping up its IL-6 inhibitor Actemra to treat dangerous complicationsin COVID-19 patients. Sale2020/5/26
-
Takeda receives China approval for Adcetris to treat lymphomaTakeda China has received approval from the country’s National Medical Products Administration (NMPA) for Adcetris (brentuximab vedotin) to treat relapsed or refractory systemic anaplastic large cell2020/5/25
-
GlaxoSmithKline signs manufacture deal with Samsung BiologicsGlaxoSmithKline has signed an agreement with South Korea-based Samsung Biologics for additional capacity to manufacture and supply its biopharmaceutical therapies. According to the terms of the deal,2020/5/22
-
AstraZeneca gets $1bn from US BARDA to support Covid-19 vaccineUK-based pharmaceutical company AstraZeneca has received more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) to develop, manufacture and deliver a Covid-19 vacci2020/5/21
-
Bharat Biotech and Thomas Jefferson partner on Covid-19 vaccineIndia-based Bharat Biotech hasentered into an exclusive agreement to develop a Covid-19 vaccine candidate created at Thomas Jefferson UniversityinPhiladelphia, US. Infectious Diseases expert professo2020/5/21
-
Roche enters $135m drug discovery deal with Vividion TherapeuticsRoche has signed an exclusive worldwide option and licence agreement with US-based biotechnology firm Vividion Therapeutics to discover and develop small molecules for various therapeutic targets. Un2020/5/20